Bionomics Limited
(NASDAQ:BNOX)
$1.55
-0.19 (-10.92%)
At Close: 4:00 PM
Bionomics Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
Bionomics Stock Price Today
Bionomics Limited (BNOX) stock declined over -10.92% intraday to trade at $1.55 a share on NASDAQ. The stock opened with a gain of 45.40% at $2.53 and touched an intraday high of $2.65, falling -10.92% against the last close of $1.74. The Bionomics Limited in stock market went to a low of $2.45 during the session.
Bionomics Stock Snapshot
$1.74
Prev. Close
12.65 Million
Market Cap
$2.45
Day Low
$2.53
Open
8.16 Million
Number of Shares
$2.65
Day High
N/A
P/E ratio
-2.63
EPS (TTM)
0.01
Cash Flow per Share
N/A
Free Float in %
4.06
Book Value
214933.00
Volume
Bionomics Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta-0.14
Sales or Revenue$649.61 Thousands
5Y Sales Change-73.75%
Fiscal Year EndsJun. 2023
SectorHealthcare
IndustryBiotechnology
About Company
Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder. It also develops BNC375, a small molecule therapeutics for the treatment of cognitive impairment in Alzheimer's disease; BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, a vascular disrupting agent, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer, and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited has a licensing agreement with Merck & Co., Inc. The company was incorporated in 1996 and is based in Eastwood, Australia.
Peers
Frequently Asked Questions
What is the current Bionomics Limited (BNOX) stock price?
Bionomics Limited (NASDAQ: BNOX) stock price is $1.55 in the last trading session. During the trading session, BNOX stock reached the peak price of $2.65 while $2.45 was the lowest point it dropped to. The percentage change in BNOX stock occurred in the recent session was -10.92% while the dollar amount for the price change in BNOX stock was -$0.19.
BNOX's industry and sector of operation?
The NASDAQ listed BNOX is part of Biotechnology industry that operates in the broader Healthcare sector. Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia and the United States. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which has completed phase 2 clinical trial for the treatment of social anxiety disorder and post-traumatic stress disorder.
Who are the executives of BNOX?
Dr. Errol B. De Souza Ph.D.
Executive Chairman
Dr. Spyridon Papapetropoulos M.D., Ph.D.
Chief Executive Officer & Pres
Mr. Connor Bernstein M.Sc.
Vice President of Strategy & Corporation Devel.
Dr. Spyridon Papapetropoulos M.D., Ph.D.
Chief Executive Officer, Pres & Director
How BNOX did perform over past 52-week?
BNOX's closing price is 0.31% higher than its 52-week low of $0.93 where as its distance from 52-week high of $10.375 is -0.78%.
How many employees does BNOX have?
Number of BNOX employees currently stands at N/A. BNOX operates from 200 Greenhill Road, Eastwood, SA 5063, AU.
Link for BNOX official website?
Official Website of BNOX is: https://www.bionomics.com.au
How do I contact BNOX?
BNOX could be contacted at phone #61 8 8354 6100 and can also be accessed through its website. BNOX operates from 200 Greenhill Road, Eastwood, SA 5063, AU.
How many shares of BNOX are traded daily?
BNOX stock volume for the day was 214933.00 shares. The average number of BNOX shares traded daily for last 3 months was 3.66 Million.
What is the market cap of BNOX currently?
The market value of BNOX currently stands at $12.65 Million with its latest stock price at $1.55 and 8.16 Million of its shares outstanding.